Association Between PDL1 Genetic Variation and Efficacy of Apatinib Monotherapy in Patients with Previously Treated Advanced NSCLC: A Real-World Retrospective Study

BACKGROUND: This study aimed to explore associations between PDL1 polymorphisms and efficacy of apatinib for patients with previously treated advanced non–small cell lung cancer (NSCLC) in a real-world setting. METHODS: We retrospectively recruited 148 patients with previously treated advanced NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wenxia, Li, Bin, Geng, Nan, He, Xin, Ge, Hui, Wang, Ping, Ding, Cuimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232958/
https://www.ncbi.nlm.nih.gov/pubmed/34188525
http://dx.doi.org/10.2147/IJGM.S303717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232958/
https://www.ncbi.nlm.nih.gov/pubmed/34188525
http://dx.doi.org/10.2147/IJGM.S303717

Ejemplares similares